NO902248L - PURE-INHIBITING PEPTIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS. - Google Patents

PURE-INHIBITING PEPTIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS.

Info

Publication number
NO902248L
NO902248L NO90902248A NO902248A NO902248L NO 902248 L NO902248 L NO 902248L NO 90902248 A NO90902248 A NO 90902248A NO 902248 A NO902248 A NO 902248A NO 902248 L NO902248 L NO 902248L
Authority
NO
Norway
Prior art keywords
pharmaceuticals
pure
preparation
inhibiting peptides
peptides
Prior art date
Application number
NO90902248A
Other languages
Norwegian (no)
Other versions
NO902248D0 (en
Inventor
Wolfgang Bender
Gunter Schmidt
Andreas Knorr
Johannes-Peter Stasch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO902248D0 publication Critical patent/NO902248D0/en
Publication of NO902248L publication Critical patent/NO902248L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO90902248A 1989-06-09 1990-05-22 PURE-INHIBITING PEPTIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS. NO902248L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3918896 1989-06-09
DE3939747A DE3939747A1 (en) 1989-06-09 1989-12-01 RENININHIBITIC PEPTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS

Publications (2)

Publication Number Publication Date
NO902248D0 NO902248D0 (en) 1990-05-22
NO902248L true NO902248L (en) 1990-12-10

Family

ID=25881770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902248A NO902248L (en) 1989-06-09 1990-05-22 PURE-INHIBITING PEPTIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS.

Country Status (12)

Country Link
EP (1) EP0403828A1 (en)
JP (1) JPH0331278A (en)
KR (1) KR910000792A (en)
CN (1) CN1047870A (en)
AU (1) AU5704490A (en)
CA (1) CA2018458A1 (en)
DE (1) DE3939747A1 (en)
FI (1) FI902852A0 (en)
HU (1) HUT54385A (en)
IL (1) IL94639A0 (en)
NO (1) NO902248L (en)
PT (1) PT94278A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4038834A1 (en) * 1990-12-06 1992-06-11 Bayer Ag OPTICALLY PURE DITHIOLANYL AND DITHIANOAMINOSAURS AND THEIR DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
DE4038921A1 (en) * 1990-12-06 1992-06-11 Bayer Ag RENININHIBITIC PEPTIDES OF THE CYCLOHEXYLSTATIN TYPE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE4038947A1 (en) * 1990-12-06 1992-06-11 Bayer Ag DITHIOLANO- AND DITHIANOGLYCIN-CONTAINING RENININHIBITORIC PEPTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS
DE4215874A1 (en) * 1992-05-14 1993-11-18 Bayer Ag Dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostear type
CA2404644A1 (en) * 2000-04-10 2001-10-18 Yuichi Ishida Modulators of prorenin activity
CN104510481A (en) * 2013-09-26 2015-04-15 温州市高德医疗器械有限公司 Hypertension three-enzyme inhibitor vacuum blood collection tube and manufacturing method thereof
KR101540416B1 (en) * 2014-02-21 2015-07-30 김천기 Spats and crampons

Also Published As

Publication number Publication date
HU903766D0 (en) 1990-11-28
AU5704490A (en) 1990-12-13
IL94639A0 (en) 1991-04-15
CA2018458A1 (en) 1990-12-09
NO902248D0 (en) 1990-05-22
HUT54385A (en) 1991-02-28
EP0403828A1 (en) 1990-12-27
CN1047870A (en) 1990-12-19
PT94278A (en) 1991-02-08
KR910000792A (en) 1991-01-30
FI902852A0 (en) 1990-06-07
JPH0331278A (en) 1991-02-12
DE3939747A1 (en) 1990-12-13

Similar Documents

Publication Publication Date Title
DK374389D0 (en) ARYLBENZENOXAZOLIDINONES, THEIR PREPARATION AND USE
NO902658L (en) N-PHENYLPYRAZOLD DERIVATIVES, PREPARATIONS AND USE THEREOF.
NO902661D0 (en) RIBOZYMS, THEIR PREPARATION AND USE.
NO900469D0 (en) PIPERIDE CONNECTIONS, THEIR PREPARATION AND USE.
DK388989D0 (en) ACYLCYANOGUANIDINES, THEIR PREPARATION AND USE
DK435289D0 (en) PIPERAZINDIONS, THEIR PREPARATION AND USE
NO890491D0 (en) SKI SCALES, THEIR PREPARATION AND USE.
NO903169D0 (en) 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION.
NO903096D0 (en) THERMOTROP SEMIALIFATIC COPOLYESTERAMIDS AND THEIR PREPARATION.
NO903978L (en) PYRIDINYL-QUINOLONE COMPOUNDS, THEIR PREPARATION AND USE.
NO912271D0 (en) SOMATOSTATIN PREPARATIONS, THEIR PREPARATION AND USE.
DK60893D0 (en) PIPERIDE INGREDIENTS, THEIR PREPARATION AND USE
NO902248L (en) PURE-INHIBITING PEPTIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS.
NO884671D0 (en) NEW FLOURMETOXYPHENYLNEDHYDROPYRIDINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS.
DK489889D0 (en) DIHYDROPYRIDINAMIDES, THEIR PREPARATION AND USE IN PHARMACEUTICALS
DK698188D0 (en) PEPTIDES, THEIR PREPARATION AND USE
DK225089D0 (en) 2-ADAMANTYL-4-ISOTHIAZOLIN-3-ONES, THEIR PREPARATION AND USE
NO900926L (en) SUBSTITUTED (QUINOLIN-2-YL-METOXY) PHENYL-N, N'-SULPHONYLURINE INGREDIENTS, THEIR PREPARATION AND USE IN PHARMACEUTICALS.
NO901629D0 (en) DIFFERENT PLASTIC DISPERSIONS, THEIR PREPARATION AND USE.
NO892570L (en) POLYSILAZANES, THEIR PREPARATION AND USE.
DK703588A (en) PAI-1 BLOCKING PEPTIDES, THEIR PREPARATION AND USE
DK592389A (en) PENEMDERIVATIVES, THEIR PREPARATION AND USE
NO900275L (en) BENZOPYRAND DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICALS.
DK10487D0 (en) 4-AMINOARYLDIHYDROPYRIDYLACTONES, THEIR PREPARATION AND USE IN PHARMACEUTICALS
DK581487A (en) 2,6-DIAMINO-3-HALOGENBENZYLPYRIDINES AND PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS